Multiple cycles of intermittent chemotherapy in metastatic androgen-independent prostate cancer

Recently, completed phase III studies demonstrated a survival benefit for a fixed number of cycles of docetaxel-containing chemotherapy treatment of androgen-independent prostate cancer (AIPC). Management of patients who respond well to initial chemotherapy for AIPC remains ill-defined. We previousl...

Descripción completa

Detalles Bibliográficos
Autores principales: Beer, T M, Garzotto, M, Henner, W D, Eilers, K M, Wersinger, E M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409932/
https://www.ncbi.nlm.nih.gov/pubmed/15467765
http://dx.doi.org/10.1038/sj.bjc.6602198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409932/
https://www.ncbi.nlm.nih.gov/pubmed/15467765
http://dx.doi.org/10.1038/sj.bjc.6602198

Ejemplares similares